[6] [7] For weight management, NICE technology appraisals (TA875 for Wegovy, TA664 for Saxenda) specify use within specialist weight management services for people with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and following unsuccessful lifestyle interventions
Some practitioners prefer stacked approaches because healing often involves multiple pathways simultaneously
"Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: A systematic review of the literature and future perspectives." International Journal of Lower Extremity Wounds
A healthcare provider can assess individual risk factors and recommend appropriate dosing strategies
The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis
Because the program allows for individualized modification, patients are not locked into a single dose or rigid protocol